Deep Dive: Deep Dive Into an Untraditional Path to the C-Suite
On this episode of Deep Dive, we learn how Jeffrey Nau, PhD, took the road less traveled to his role as President and CEO at Oyster Point Pharma. His background is unique in that he brings a life-long dedication to the field of ophthalmology and an ability to understand the science in this specific space. Dr. Nau takes us on his journey, where he started as a technician with a multispecialty ophthalmology practice and prepared patients for pre-LASIK consultations and captured retinal images. Next, he worked at an eye bank where he learned how to harvest organs and corneal tissues. From there, he earned his Master of Medical Science with Drexel University’s College of Medicine and spent time at Wills Eye Hospital in Philadelphia conducting ocular oncology research. He transitioned this experience into ophthalmic drug development and offers advice for clinicians who might consider a move from clinical medicine to the pharmaceutical industry.
Related Articles
- Deep Dive: Into Improving Patient Outcomes Through AI
August 16th 2023
- Behind the Science: Behind Chemotherapy Shortages
August 15th 2023
- Deep Dive: Into Types of Chromatography
August 15th 2023
- Deep Dive: Into Clinical Trials & Reproductive Health
August 4th 2023
- Deep Dive: Into Diabetic Retinopathy
August 3rd 2023
- Deep Dive: Into AHN’s Fertility Clinic
August 2nd 2023